Annual D&A
$53.20 M
+$1.90 M+3.70%
31 December 2023
Summary:
United Therapeutics annual depreciation & amortization is currently $53.20 million, with the most recent change of +$1.90 million (+3.70%) on 31 December 2023. During the last 3 years, it has risen by +$3.30 million (+6.61%). UTHR annual D&A is now at all-time high.UTHR Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$19.10 M
+$400.00 K+2.14%
30 September 2024
Summary:
United Therapeutics quarterly depreciation & amortization is currently $19.10 million, with the most recent change of +$400.00 thousand (+2.14%) on 30 September 2024. Over the past year, it has increased by +$5.80 million (+43.61%). UTHR quarterly D&A is now at all-time high.UTHR Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$66.50 M
+$5.80 M+9.56%
30 September 2024
Summary:
United Therapeutics TTM depreciation & amortization is currently $66.50 million, with the most recent change of +$5.80 million (+9.56%) on 30 September 2024. Over the past year, it has increased by +$13.80 million (+26.19%). UTHR TTM D&A is now at all-time high.UTHR TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
UTHR Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +3.7% | +43.6% | +26.2% |
| 3 y3 years | +6.6% | +54.0% | +31.9% |
| 5 y5 years | +48.2% | +50.4% | +51.5% |
UTHR Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +6.6% | at high | +54.0% | at high | +33.3% |
| 5 y | 5 years | at high | +48.2% | at high | +61.9% | at high | +51.5% |
| alltime | all time | at high | +4192.3% | at high | +1464.3% | at high | +4606.9% |
United Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.10 M(+2.1%) | $66.50 M(+9.6%) |
| June 2024 | - | $18.70 M(+24.7%) | $60.70 M(+10.6%) |
| Mar 2024 | - | $15.00 M(+9.5%) | $54.90 M(+3.2%) |
| Dec 2023 | $53.20 M(+3.7%) | $13.70 M(+3.0%) | $53.20 M(+0.9%) |
| Sept 2023 | - | $13.30 M(+3.1%) | $52.70 M(+0.8%) |
| June 2023 | - | $12.90 M(-3.0%) | $52.30 M(+0.4%) |
| Mar 2023 | - | $13.30 M(+0.8%) | $52.10 M(+1.6%) |
| Dec 2022 | $51.30 M(+2.8%) | $13.20 M(+2.3%) | $51.30 M(+1.2%) |
| Sept 2022 | - | $12.90 M(+1.6%) | $50.70 M(+1.0%) |
| June 2022 | - | $12.70 M(+1.6%) | $50.20 M(+0.6%) |
| Mar 2022 | - | $12.50 M(-0.8%) | $49.90 M(0.0%) |
| Dec 2021 | $49.90 M(0.0%) | $12.60 M(+1.6%) | $49.90 M(-1.0%) |
| Sept 2021 | - | $12.40 M(0.0%) | $50.40 M(+1.2%) |
| June 2021 | - | $12.40 M(-0.8%) | $49.80 M(-0.4%) |
| Mar 2021 | - | $12.50 M(-4.6%) | $50.00 M(+0.2%) |
| Dec 2020 | $49.90 M(+8.7%) | $13.10 M(+11.0%) | $49.90 M(+1.2%) |
| Sept 2020 | - | $11.80 M(-6.3%) | $49.30 M(-1.8%) |
| June 2020 | - | $12.60 M(+1.6%) | $50.20 M(+4.6%) |
| Mar 2020 | - | $12.40 M(-0.8%) | $48.00 M(+4.6%) |
| Dec 2019 | $45.90 M(+27.9%) | $12.50 M(-1.6%) | $45.90 M(+4.6%) |
| Sept 2019 | - | $12.70 M(+22.1%) | $43.90 M(+8.1%) |
| June 2019 | - | $10.40 M(+1.0%) | $40.60 M(+6.0%) |
| Mar 2019 | - | $10.30 M(-1.9%) | $38.30 M(+6.7%) |
| Dec 2018 | $35.90 M(+15.8%) | $10.50 M(+11.7%) | $35.90 M(+8.5%) |
| Sept 2018 | - | $9.40 M(+16.0%) | $33.10 M(+5.4%) |
| June 2018 | - | $8.10 M(+2.5%) | $31.40 M(+1.3%) |
| Mar 2018 | - | $7.90 M(+2.6%) | $31.00 M(0.0%) |
| Dec 2017 | $31.00 M(-1.9%) | $7.70 M(0.0%) | $31.00 M(-0.3%) |
| Sept 2017 | - | $7.70 M(0.0%) | $31.10 M(-1.6%) |
| June 2017 | - | $7.70 M(-2.5%) | $31.60 M(-0.6%) |
| Mar 2017 | - | $7.90 M(+1.3%) | $31.80 M(+0.6%) |
| Dec 2016 | $31.60 M(-4.0%) | $7.80 M(-4.9%) | $31.60 M(-0.3%) |
| Sept 2016 | - | $8.20 M(+3.8%) | $31.70 M(-0.3%) |
| June 2016 | - | $7.90 M(+2.6%) | $31.80 M(-1.5%) |
| Mar 2016 | - | $7.70 M(-2.5%) | $32.30 M(-1.8%) |
| Dec 2015 | $32.90 M(+2.2%) | $7.90 M(-4.8%) | $32.90 M(-2.9%) |
| Sept 2015 | - | $8.30 M(-1.2%) | $33.89 M(+0.6%) |
| June 2015 | - | $8.40 M(+1.2%) | $33.69 M(+2.3%) |
| Mar 2015 | - | $8.30 M(-6.6%) | $32.94 M(+2.3%) |
| Dec 2014 | $32.20 M(+3.0%) | $8.89 M(+9.6%) | $32.20 M(+3.7%) |
| Sept 2014 | - | $8.11 M(+6.1%) | $31.07 M(+1.5%) |
| June 2014 | - | $7.64 M(+1.0%) | $30.62 M(-0.1%) |
| Mar 2014 | - | $7.57 M(-2.4%) | $30.66 M(-1.9%) |
| Dec 2013 | $31.26 M(+15.2%) | $7.75 M(+1.2%) | $31.26 M(+1.5%) |
| Sept 2013 | - | $7.66 M(-0.2%) | $30.80 M(+2.5%) |
| June 2013 | - | $7.68 M(-5.9%) | $30.05 M(+4.8%) |
| Mar 2013 | - | $8.16 M(+12.0%) | $28.66 M(+5.6%) |
| Dec 2012 | $27.14 M(+32.2%) | $7.29 M(+5.4%) | $27.14 M(+9.7%) |
| Sept 2012 | - | $6.92 M(+9.9%) | $24.75 M(+8.4%) |
| June 2012 | - | $6.29 M(-5.4%) | $22.83 M(+6.8%) |
| Mar 2012 | - | $6.65 M(+35.7%) | $21.37 M(+4.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $20.54 M(+14.6%) | $4.90 M(-1.9%) | $20.54 M(+6.0%) |
| Sept 2011 | - | $4.99 M(+3.2%) | $19.38 M(-0.2%) |
| June 2011 | - | $4.84 M(-16.7%) | $19.41 M(+1.3%) |
| Mar 2011 | - | $5.81 M(+55.4%) | $19.16 M(+6.9%) |
| Dec 2010 | $17.92 M(+57.3%) | $3.74 M(-25.6%) | $17.92 M(-5.2%) |
| Sept 2010 | - | $5.03 M(+9.7%) | $18.90 M(+15.4%) |
| June 2010 | - | $4.58 M(+0.3%) | $16.38 M(+15.4%) |
| Mar 2010 | - | $4.57 M(-3.2%) | $14.20 M(+24.6%) |
| Dec 2009 | $11.39 M(+151.2%) | $4.72 M(+88.5%) | $11.39 M(+41.3%) |
| Sept 2009 | - | $2.50 M(+4.2%) | $8.06 M(+6.7%) |
| June 2009 | - | $2.40 M(+36.1%) | $7.56 M(+49.1%) |
| Mar 2009 | - | $1.76 M(+27.0%) | $5.07 M(+11.8%) |
| Dec 2008 | $4.54 M(+32.4%) | $1.39 M(-30.6%) | $4.54 M(-37.1%) |
| Sept 2008 | - | $2.00 M(-2455.3%) | $7.21 M(+74.1%) |
| June 2008 | - | -$85.00 K(-106.9%) | $4.14 M(-7.6%) |
| Mar 2008 | - | $1.23 M(-69.8%) | $4.49 M(+30.9%) |
| Dec 2007 | $3.43 M(+134.1%) | $4.07 M(-480.4%) | $3.43 M(-656.3%) |
| Sept 2007 | - | -$1.07 M(-514.3%) | -$616.00 K(-172.1%) |
| June 2007 | - | $258.00 K(+50.9%) | $854.00 K(-22.2%) |
| Mar 2007 | - | $171.00 K(+612.5%) | $1.10 M(-25.0%) |
| Dec 2006 | $1.46 M(-39.4%) | $24.00 K(-94.0%) | $1.46 M(-28.9%) |
| Sept 2006 | - | $401.00 K(-20.1%) | $2.06 M(-8.5%) |
| June 2006 | - | $502.00 K(-6.5%) | $2.25 M(-4.7%) |
| Mar 2006 | - | $537.00 K(-13.1%) | $2.36 M(-2.2%) |
| Dec 2005 | $2.41 M(+6.1%) | $618.00 K(+4.4%) | $2.41 M(+0.1%) |
| Sept 2005 | - | $592.00 K(-3.6%) | $2.41 M(+0.7%) |
| June 2005 | - | $614.00 K(+4.1%) | $2.40 M(+5.0%) |
| Mar 2005 | - | $590.00 K(-4.1%) | $2.28 M(+0.3%) |
| Dec 2004 | $2.28 M(-2.1%) | $615.00 K(+6.8%) | $2.28 M(-1.1%) |
| Sept 2004 | - | $576.00 K(+15.0%) | $2.30 M(+0.3%) |
| June 2004 | - | $501.00 K(-14.2%) | $2.29 M(-4.1%) |
| Mar 2004 | - | $584.00 K(-8.8%) | $2.39 M(+2.8%) |
| Dec 2003 | $2.33 M(-25.8%) | $640.00 K(+12.5%) | $2.33 M(+6.9%) |
| Sept 2003 | - | $569.00 K(-4.8%) | $2.17 M(+0.1%) |
| June 2003 | - | $598.00 K(+15.4%) | $2.17 M(-17.3%) |
| Mar 2003 | - | $518.00 K(+5.7%) | $2.63 M(-16.1%) |
| Dec 2002 | $3.13 M(-10.8%) | $490.00 K(-13.6%) | $3.13 M(-22.5%) |
| Sept 2002 | - | $567.00 K(-46.2%) | $4.05 M(-6.3%) |
| June 2002 | - | $1.05 M(+2.9%) | $4.32 M(+7.4%) |
| Mar 2002 | - | $1.02 M(-26.9%) | $4.02 M(+14.4%) |
| Dec 2001 | $3.52 M(-4510.3%) | $1.40 M(+66.8%) | $3.52 M(+66.5%) |
| Sept 2001 | - | $839.70 K(+11.1%) | $2.11 M(+64.5%) |
| June 2001 | - | $755.70 K(+45.5%) | $1.28 M(+127.8%) |
| Mar 2001 | - | $519.30 K(<-9900.0%) | $563.40 K(-806.9%) |
| Dec 2000 | -$79.70 K(-93.9%) | -$4200.00(-133.9%) | -$79.70 K(-94.6%) |
| Sept 2000 | - | $12.40 K(-65.5%) | -$1.48 M(+14.6%) |
| June 2000 | - | $35.90 K(-129.0%) | -$1.29 M(-9.5%) |
| Mar 2000 | - | -$123.80 K(-91.2%) | -$1.42 M(+9.5%) |
| Dec 1999 | -$1.30 M | -$1.40 M(-800.0%) | -$1.30 M(-1400.0%) |
| Sept 1999 | - | $200.00 K(-300.0%) | $100.00 K(-200.0%) |
| June 1999 | - | -$100.00 K | -$100.00 K |
FAQ
- What is United Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for United Therapeutics?
- What is United Therapeutics annual D&A year-on-year change?
- What is United Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for United Therapeutics?
- What is United Therapeutics quarterly D&A year-on-year change?
- What is United Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for United Therapeutics?
- What is United Therapeutics TTM D&A year-on-year change?
What is United Therapeutics annual depreciation & amortization?
The current annual D&A of UTHR is $53.20 M
What is the all time high annual D&A for United Therapeutics?
United Therapeutics all-time high annual depreciation & amortization is $53.20 M
What is United Therapeutics annual D&A year-on-year change?
Over the past year, UTHR annual depreciation & amortization has changed by +$1.90 M (+3.70%)
What is United Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of UTHR is $19.10 M
What is the all time high quarterly D&A for United Therapeutics?
United Therapeutics all-time high quarterly depreciation & amortization is $19.10 M
What is United Therapeutics quarterly D&A year-on-year change?
Over the past year, UTHR quarterly depreciation & amortization has changed by +$5.80 M (+43.61%)
What is United Therapeutics TTM depreciation & amortization?
The current TTM D&A of UTHR is $66.50 M
What is the all time high TTM D&A for United Therapeutics?
United Therapeutics all-time high TTM depreciation & amortization is $66.50 M
What is United Therapeutics TTM D&A year-on-year change?
Over the past year, UTHR TTM depreciation & amortization has changed by +$13.80 M (+26.19%)